WKSI. The Company is a “well-known seasoned issuer” as defined in Rule 405 of the Securities Act.
Appears in 10 contracts
Samples: Underwriting Agreement (Akero Therapeutics, Inc.), Underwriting Agreement (Akero Therapeutics, Inc.), Underwriting Agreement (Akero Therapeutics, Inc.)
